Efficacy and Immunological Evaluation of Telitacicept and Low Dose IL2 in the Treatment of Systemic Lupus Erythematosus
Clinical trial NCT05339217 · UNKNOWN
Trial details
- NCT number
- NCT05339217
- Sponsor
- Liu Tian
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-07
- Primary completion
- 2025-07-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.